L. Cheng

A Retrospective Observation of Treatment Outcomes Using Decitabine-Combined Standard Conditioning Regimens Before Transplantation in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Ting Sun, Chen Xu, Liang-ding Hu, 2021, Frontiers in Oncology.

Potential effect of epigenetic drugs in the treatment of multiple-site extramedullary plasmacytoma involving the respiratory system: a case report and review of the literature

Quan-shun Wang, Xiaoning Gao, L. Cheng, 2021, Translational cancer research.

OTT_A_200005 5013..5023

Y. Jing, Li Yu, Daihong Liu, 2019 .

Clinical efficacy of decitabine in combination with standard-dose cytarabine, aclarubicin hydrochloride, and granulocyte colony-stimulating factor in the treatment of young patients with newly diagnosed acute myeloid leukemia

Y. Jing, Li Yu, Daihong Liu, 2019, OncoTargets and therapy.

Case report: First report of haploidentical allogeneic hematopoietic stem cell transplantation from donors with mild alpha-thalassemia for acute leukemia

Yuhui Yang, H. Ning, L. Cheng, 2022, Frontiers in Oncology.

Clinical efficacy of decitabine in combination with standard-dose cytarabine, aclarubicin hydrochloride, and granulocyte colony-stimulating factor in the treatment of young patients with newly diagnosed acute myeloid leukemia

Y. Jing, Li Yu, Daihong Liu, 2019, OncoTargets and therapy.

[Clinical Characteristics and Prognosis of U2AF1 Mutation in Patients with Acute Myeloid Leukemia].

Z. Gu, Yuan-yuan Xu, L. Dou, 2020 .